Royce & Associates LP Purchases Shares of 75,000 Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Royce & Associates LP purchased a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the third quarter, Holdings Channel.com reports. The fund purchased 75,000 shares of the company’s stock, valued at approximately $1,260,000.

Other hedge funds have also recently modified their holdings of the company. Seven Grand Managers LLC acquired a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $2,515,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Guardian Pharmacy Services in the third quarter worth $5,460,000. Finally, Stephens Inc. AR acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth $189,000.

Wall Street Analyst Weigh In

GRDN has been the topic of several research reports. Stephens initiated coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price on the stock. Truist Financial raised their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. Finally, Raymond James started coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued an “outperform” rating and a $21.00 target price on the stock.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was purchased at an average price of $14.00 per share, for a total transaction of $499,996.00. Following the purchase, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Guardian Pharmacy Services Stock Performance

NYSE:GRDN opened at $21.56 on Wednesday. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last issued its earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million during the quarter, compared to analysts’ expectations of $303.21 million. Equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.81 earnings per share for the current fiscal year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.